PFIZER INC Other Restructuring Costs
PFIZER INC (PFE) reported Other Restructuring Costs of $13.00 million for the 3-month period ending 2014-06-29, per its 10-Q filed 2014-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2014-08-07
- PFIZER INC other restructuring costs for the quarter ending 2014-06-29 was $13.00M, a 8.33% increase year-over-year.
- PFIZER INC other restructuring costs for the quarter ending 2014-03-30 was $6.00M, a 94.17% decline year-over-year.
- PFIZER INC other restructuring costs for the quarter ending 2013-06-30 was $12.00M.
- PFIZER INC other restructuring costs for the quarter ending 2013-03-31 was $103.00M, a 836.36% increase year-over-year.
- PFIZER INC other restructuring costs for fiscal 2011 was $127.00M, a 33.51% decline from fiscal 2010.
- PFIZER INC other restructuring costs for fiscal 2010 was $191.00M, a 29.26% decline from fiscal 2009.
- PFIZER INC other restructuring costs for fiscal 2009 was $270.00M, a 241.77% increase from fiscal 2008.
- PFIZER INC other restructuring costs for fiscal 2008 was $79.00M.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 9 month | Other Restructuring Costs 12 month | Other Restructuring Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2014-06-29 | $13.00M 10-Q · filed 2014-08-07 | $19.00M 10-Q · filed 2014-08-07 | |||
| 2014-03-30 | $6.00M 10-Q · filed 2014-05-08 | ||||
| 2013-06-30 | $12.00M 10-Q · filed 2014-08-07 | $115.00M 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | $103.00M 10-Q · filed 2014-05-08 | ||||
| 2012-04-01 | $11.00M 10-Q · filed 2012-05-10 | $42.00M derived: sum of 2 quarters · filed 2012-05-10 | $82.00M derived: sum of 3 quarters · filed 2012-05-10 | $125.00M derived: sum of 4 quarters · filed 2012-05-10 | |
| 2011-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $71.00M derived: sum of 2 quarters · filed 2012-02-28 | $114.00M derived: sum of 3 quarters · filed 2012-02-28 | $127.00M 10-K · filed 2012-02-28 | |
| 2011-10-02 | $40.00M 10-Q · filed 2011-11-10 | $83.00M derived: sum of 2 quarters · filed 2011-11-10 | $96.00M 10-Q · filed 2011-11-10 | $139.00M derived: sum of 4 quarters · filed 2012-05-10 | |
| 2011-07-03 | $43.00M 10-Q · filed 2011-08-11 | $56.00M 10-Q · filed 2011-08-11 | $99.00M derived: sum of 3 quarters · filed 2012-05-10 | $166.00M derived: sum of 4 quarters · filed 2012-05-10 | |
| 2011-04-03 | $13.00M 10-Q · filed 2012-05-10 | $56.00M derived: sum of 2 quarters · filed 2012-05-10 | $123.00M derived: sum of 3 quarters · filed 2012-05-10 | $178.00M derived: sum of 4 quarters · filed 2012-05-10 | |
| 2010-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $110.00M derived: sum of 2 quarters · filed 2012-02-28 | $165.00M derived: sum of 3 quarters · filed 2012-02-28 | $191.00M 10-K · filed 2012-02-28 | $192.00M 10-K · filed 2011-02-28 |
| 2010-10-03 | $67.00M 10-Q · filed 2011-11-10 | $122.00M derived: sum of 2 quarters · filed 2011-11-10 | $147.00M 10-Q · filed 2011-11-10 | $333.00M derived: sum of 4 quarters · filed 2012-02-28 | |
| 2010-07-04 | $55.00M 10-Q · filed 2011-08-11 | $80.00M 10-Q · filed 2011-08-11 | $266.00M derived: sum of 3 quarters · filed 2012-02-28 | $274.00M derived: sum of 4 quarters · filed 2012-02-28 | |
| 2010-04-04 | $25.00M 10-Q · filed 2011-05-12 | $211.00M derived: sum of 2 quarters · filed 2012-02-28 | $219.00M derived: sum of 3 quarters · filed 2012-02-28 | ||
| 2009-12-31 | $186.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $194.00M derived: sum of 2 quarters · filed 2012-02-28 | $270.00M 10-K · filed 2012-02-28 | ||
| 2009-09-27 | $8.00M 10-Q · filed 2010-11-12 | $84.00M 10-Q · filed 2010-11-12 | |||
| 2008-12-31 | $79.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |